E. Tan

First name
E.
Middle name
H.
Last name
Tan
Guo, Y. ., Raventós, B. ., Català, M. ., Elhussein, L. ., López-Güell, K. ., Tan, E. H., … Jödicke, A. M. (2024). Time Series Methods to Assess the Impact of Regulatory Action: A Study of UK Primary Care and Hospital Data on the Use of Fluoroquinolones. Pharmacoepidemiol Drug Saf, 33, e70022. http://doi.org/10.1002/pds.70022
Barclay, N. L., Burn, E. ., Delmestri, A. ., Duarte-Salles, T. ., Golozar, A. ., . Y. Man, W. ., … Newby, D. . (2024). Trends in incidence, prevalence, and survival of breast cancer in the United Kingdom from 2000 to 2021. Sci Rep, 14, 19069. http://doi.org/10.1038/s41598-024-69006-1
Barclay, N. L., Burkard, T. ., Burn, E. ., Delmestri, A. ., Dominguez, M. ., Golozar, A. ., … Newby, D. . (2024). The Impact of the COVID-19 Pandemic on Incidence and Short-Term Survival for Common Solid Tumours in the United Kingdom: A Cohort Analysis. Clin Epidemiol, 16, 417–429. http://doi.org/10.2147/clep.s463160
Tan, E. H., Rathod-Mistry, T. ., . Y. Strauss, V. ., O’Kelly, J. ., Giorgianni, F. ., Baxter, R. ., … Prieto-Alhambra, D. . (2024). Evaluating the comparability of osteoporosis treatments using propensity score and negative control outcome methods in UK and Denmark electronic health record databases. J Bone Miner Res. http://doi.org/10.1093/jbmr/zjae059
Jödicke, A. M., Tan, E. H., Robinson, D. E., Delmestri, A. ., & Prieto-Alhambra, D. . (2023). Risk of adverse events following the initiation of antihypertensives in older people with complex health needs: a self-controlled case series in the United Kingdom. Age Ageing, 52. http://doi.org/10.1093/ageing/afad177
Tan, E. H., Robinson, D. E., Jödicke, A. M., Mosseveld, M. ., Bødkergaard, K. ., Reyes, C. ., … Sanchez-Santos, M. T. (2023). Drug utilization analysis of osteoporosis medications in seven European electronic health databases. Osteoporos Int. http://doi.org/10.1007/s00198-023-06837-0